Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Postoperative Complications 1Pancreatic Neoplasms 1Pancreatic Fistula 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoprene × Gastrointestinal × Clear all
NCT03738787 2021-10-05

Treatment of the Pancreatic Stump With NeopreneĀ®-Based Glue After High-risk Pancreatoduodenectomy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
40 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚔